MicroAlgo Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $60M-20.3% YoYTTM through 31 Dec 2025
Net Income $18.1M+149.0% YoYTTM through 31 Dec 2025
Free Cash Flow $13.1MTTM through 31 Dec 2025
Margins
| Current | |
|---|---|
| Gross Margin | 25.8% |
| EBITDA Margin | 5.3% |
| Operating Margin | 5.3% |
| Net Margin | 30.2% |
Returns
5.5%ROE
5.2%ROA
11.7%ROIC
Balance Sheet Health
Debt / Equity0.00x
Current Ratio22.53x
Net Debt$0
Cash & Equivalents$174.8M
Quality Metrics
Altman Z-Score2.85
FCF Margin21.8%
Multi-Year Trend
RevenueFY2025: $422M
Diluted EPS$2.12TTMFY2025: $16.65
Dividend
No dividend
Capital Allocation
R&D Spend$9M
Capex Intensity1,930.2%
Financials converted at 6.9961 from RMB.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.